Medicine Shortages in the European Union
Ken AertsMedicine shortages remain a growing challenge across Europe, including in the Netherlands. These shortages can affect the continuity of treatment and place additional pressure on pharmacies, healthcare professionals and patients who depend on timely access to essential medicines.
Orelia Pharma seeks, where possible, to contribute to mitigating these shortages by collaborating with trusted suppliers and healthcare partners. By focusing on reliable sourcing and responsible distribution, we support continuity of supply and help safeguard patient access to essential medicines.
Ensuring access to medicines requires more than availability alone. It also depends on strong supply relationships, responsible distribution practices and continued cooperation across the pharmaceutical and healthcare chain.
This video provides additional context on the growing issue of medicine shortages and the wider impact on healthcare systems and patient access.
As medicine shortages continue to affect multiple markets, responsible pharmaceutical organisations have an important role to play in maintaining supply resilience. This includes working with dependable partners, identifying appropriate sourcing solutions and supporting healthcare providers with continuity where possible.
At Orelia Pharma, this aligns closely with our broader mission to contribute to sustainable access to medicines through quality, reliability and responsible collaboration within the pharmaceutical supply chain.